Dogmatil



Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 30.3%
Drug Use For Unknown Indication 13.7%
Depression 12.0%
Hypertension 8.6%
Cancer Pain 6.9%
Cardiac Failure 3.4%
Haematuria 3.4%
Dizziness 2.9%
Drug Exposure During Pregnancy 2.3%
Dyspepsia 2.3%
Atrial Fibrillation 1.7%
Cystitis 1.7%
Epilepsy 1.7%
Prophylaxis Of Nausea And Vomiting 1.7%
Thyroid Disorder 1.7%
Anxiety 1.1%
Asthma 1.1%
Neuralgia 1.1%
Psychotic Disorder 1.1%
Type 1 Diabetes Mellitus 1.1%
Pneumonia Aspiration 12.1%
Toxic Epidermal Necrolysis 9.1%
Hypokalaemia 6.1%
Orthostatic Hypotension 6.1%
Pancreatitis Relapsing 6.1%
Pulmonary Embolism 6.1%
Pupils Unequal 6.1%
Thrombocytopenia 6.1%
Thyroid Disorder 6.1%
Tumour Associated Fever 6.1%
Agranulocytosis 3.0%
Angioedema 3.0%
Aphasia 3.0%
Drug Exposure During Pregnancy 3.0%
Headache 3.0%
Hepatic Enzyme Increased 3.0%
Hyperhidrosis 3.0%
Hyperprolactinaemia 3.0%
Metrorrhagia 3.0%
Pain In Extremity 3.0%
Concomitant
Depression 20.4%
Drug Use For Unknown Indication 20.4%
Product Used For Unknown Indication 15.9%
Hypertension 5.8%
Anxiety 4.6%
Headache 3.4%
Psoriasis 3.0%
Schizophrenia 3.0%
Epilepsy 2.7%
Convulsion 2.4%
Schizophrenia, Disorganised Type 2.4%
Non-small Cell Lung Cancer 2.1%
Prophylaxis 2.1%
Osteoarthritis 1.8%
Pneumonia 1.8%
Vertigo 1.8%
Asthmatic Crisis 1.5%
Constipation 1.5%
Convulsion Prophylaxis 1.5%
Diabetes Mellitus 1.5%
Loss Of Consciousness 8.6%
Pancreatitis Acute 8.6%
Small Cell Lung Cancer Metastatic 6.9%
Vertigo 6.9%
Viral Infection 6.9%
Vomiting 6.9%
Hyponatraemia 5.2%
Respiratory Disorder 5.2%
Spontaneous Haematoma 5.2%
Tremor 5.2%
Blood Immunoglobulin E Increased 3.4%
Cholestasis 3.4%
Drug Interaction 3.4%
Fluid Retention 3.4%
Hiccups 3.4%
International Normalised Ratio Decreased 3.4%
Ophthalmoplegia 3.4%
Overdose 3.4%
Palpitations 3.4%
Personality Disorder 3.4%
Interacting
Depression 100.0%
Nausea 100.0%